Sevim Baybaş

991 total citations
40 papers, 481 citations indexed

About

Sevim Baybaş is a scholar working on Psychiatry and Mental health, Neurology and Pathology and Forensic Medicine. According to data from OpenAlex, Sevim Baybaş has authored 40 papers receiving a total of 481 indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Psychiatry and Mental health, 10 papers in Neurology and 6 papers in Pathology and Forensic Medicine. Recurrent topics in Sevim Baybaş's work include Epilepsy research and treatment (12 papers), Pharmacological Effects and Toxicity Studies (6 papers) and Parkinson's Disease Mechanisms and Treatments (5 papers). Sevim Baybaş is often cited by papers focused on Epilepsy research and treatment (12 papers), Pharmacological Effects and Toxicity Studies (6 papers) and Parkinson's Disease Mechanisms and Treatments (5 papers). Sevim Baybaş collaborates with scholars based in Türkiye and United States. Sevim Baybaş's co-authors include Ayhan Köksal, Dilek Ataklı, Musa Öztürk, Ahmet Dırıcan, Baki Arpacı, Aysun Soysal, Özlem Doğu, Burcu Ersöz Hüseyinsinoğlu, Arzu Razak Özdi̇nçler and Peykan Gökalp and has published in prestigious journals such as SHILAP Revista de lepidopterología, Journal of the Neurological Sciences and Cephalalgia.

In The Last Decade

Sevim Baybaş

36 papers receiving 463 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Sevim Baybaş Türkiye 14 285 178 105 53 52 40 481
Thilinie Rajapakse Canada 12 227 0.8× 161 0.9× 76 0.7× 69 1.3× 78 1.5× 26 632
Reda Badry Egypt 14 170 0.6× 84 0.5× 92 0.9× 57 1.1× 127 2.4× 37 497
Michael Rotstein Israel 13 85 0.3× 301 1.7× 152 1.4× 52 1.0× 77 1.5× 21 930
Ángel Golimstok Argentina 10 248 0.9× 74 0.4× 103 1.0× 47 0.9× 71 1.4× 24 387
Jamir Pitton Rissardo Brazil 13 176 0.6× 71 0.4× 315 3.0× 78 1.5× 31 0.6× 162 603
Jesús Hernández‐Gallego Spain 10 216 0.8× 46 0.3× 63 0.6× 44 0.8× 50 1.0× 33 496
Luciano de Paola Brazil 15 272 1.0× 135 0.8× 76 0.7× 100 1.9× 69 1.3× 58 617
Didier Bouhassira France 15 191 0.7× 86 0.5× 170 1.6× 84 1.6× 145 2.8× 32 930
Monica Storti Italy 11 232 0.8× 97 0.5× 85 0.8× 47 0.9× 73 1.4× 16 445
Marlene Alonso-Juárez Mexico 12 111 0.4× 43 0.2× 218 2.1× 81 1.5× 20 0.4× 34 433

Countries citing papers authored by Sevim Baybaş

Since Specialization
Citations

This map shows the geographic impact of Sevim Baybaş's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sevim Baybaş with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sevim Baybaş more than expected).

Fields of papers citing papers by Sevim Baybaş

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sevim Baybaş. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sevim Baybaş. The network helps show where Sevim Baybaş may publish in the future.

Co-authorship network of co-authors of Sevim Baybaş

This figure shows the co-authorship network connecting the top 25 collaborators of Sevim Baybaş. A scholar is included among the top collaborators of Sevim Baybaş based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sevim Baybaş. Sevim Baybaş is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Öztürk, Musa, et al.. (2022). Assessment of serum MMP-9, TIMP-1 levels and MMP-9/TIMP-1 ratio in migraine patients with and without aura. Ideggyógyászati Szemle. 75(9-10). 341–349. 5 indexed citations
2.
Baybaş, Sevim, et al.. (2017). Development and validation of the stigma scale for epilepsy in Turkey. Epilepsy & Behavior. 67. 84–90. 26 indexed citations
3.
Baybaş, Sevim, et al.. (2017). Stigma accounts for depression in patients with epilepsy. Epilepsy & Behavior. 78. 1–6. 40 indexed citations
4.
Köksal, Ayhan, et al.. (2016). The relation of serum uric acid levels with l-Dopa treatment and progression in patients with Parkinson’s disease. Neurological Sciences. 37(5). 743–747. 29 indexed citations
5.
Hüseyinsinoğlu, Burcu Ersöz, et al.. (2016). Physical Activity Level of Ambulatory Stroke Patients: Is it Related to Neuropsychological Factors?. Nöro Psikiyatri Arşivi. 54(2). 155–161. 9 indexed citations
6.
Köksal, Ayhan, et al.. (2015). Independent effect of fatigue on health-related quality of life in patients with idiopathic Parkinson’s disease. Neurological Sciences. 36(12). 2221–2226. 34 indexed citations
8.
Köksal, Ayhan, et al.. (2014). PSİKOJENİK POLİDİPSİNİN NEDEN OLDUĞU BİR HİPONATREMİK ENSEFALOPATİ OLGUSU. DergiPark (Istanbul University). 1 indexed citations
9.
Köksal, Ayhan, et al.. (2014). Evaluation of Cognitive Characteristics of Patients Developing Manifestations of Parkinsonism Secondary to Long-Term Ephedrone Use. European Neurology. 71(3-4). 208–212. 7 indexed citations
10.
Köksal, Ayhan, et al.. (2013). A case of peduncular hallucinosis presenting as a primary psychiatric disorder. Annals of Indian Academy of Neurology. 16(4). 684–684. 6 indexed citations
11.
Köksal, Ayhan, et al.. (2012). Assessment of autonomic dysfunction in Parkinson patients by electrocardiogram / Parkinson hastalarında otonomik disfonksiyonun EKG ile değerlendirilmesi. Dusunen Adam The Journal of Psychiatry and Neurological Sciences. 147–150. 3 indexed citations
12.
Öztürk, Musa, et al.. (2012). Serum lactic acid and pyruvic acid levels in patients with migraine and tension type headache. Dusunen Adam The Journal of Psychiatry and Neurological Sciences. 276–280. 6 indexed citations
13.
Köksal, Ayhan, et al.. (2012). Chronic manganese toxicity due to substance abuse in Turkish patients. Neurology India. 60(2). 224–224. 15 indexed citations
14.
Baybaş, Sevim, et al.. (2010). Isolated brain stem tuberculoma: a case report and review of the literature. Dusunen Adam The Journal of Psychiatry and Neurological Sciences. 288–292. 2 indexed citations
15.
Dayan, Colin, et al.. (2010). İnmelerde tekrarlayıcılığı etkileyen risk faktörleri. Dusunen Adam The Journal of Psychiatry and Neurological Sciences. 38–43. 1 indexed citations
16.
Baybaş, Sevim, et al.. (2010). İzole beyin sapı tüberkülomu: Bir olgu sunumu ve literatürün gözden geçirilmesi. Dusunen Adam The Journal of Psychiatry and Neurological Sciences. 288–292.
17.
Dayan, Colin, et al.. (2010). Risk factors that affect recurrence in strokes. Dusunen Adam The Journal of Psychiatry and Neurological Sciences. 38–43. 1 indexed citations
18.
Baybaş, Sevim, et al.. (2010). Frequency of Epilepsies in Family Members of Patients with Different Epileptic Syndromes. European Neurology. 65(1). 4–9. 8 indexed citations
19.
Öztürk, Musa, et al.. (2005). Evaluation of Lipid Peroxidation Representing Oxidative Stress in Patients with Migraine. SHILAP Revista de lepidopterología. 18(3). 129–135. 2 indexed citations
20.
Soysal, Aysun, et al.. (1999). Auditory event-related potentials (P300) in partial and generalized epileptic patients. Seizure. 8(2). 107–110. 26 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026